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P

ain from vaccine injections is common,
and concerns about pain contribute to vaccine hesitancy across the lifespan.1,2 Noncompliance with vaccination compromises the
individual and community benefits of immunization by contributing to outbreaks of vaccine-
preventable diseases. Individuals may also engage
in broader noncompliant behaviours if they
acquire a fear of needles as a result of negative
vaccination experiences.3 There are many evidence-based treatments to mitigate pain at the
time of vaccination; however, most are not routinely used.4,5 An independent, cross-Canada
multidisciplinary team, Help Eliminate Pain in
Kids (HELPinKIDS), assembled in 2008 to
tackle this gap in clinical care. In 2010, the
HELPinKIDS team published the first clinical
practice guideline on reducing pain during childhood vaccination.6 There are currently no guidelines on reducing pain during vaccination in adults.

Scope
The current guideline expands on and updates
the 2010 guideline with recommendations
across the lifespan. This enhanced scope led to
a revised team name of HELPinKids&Adults.
The intended audience is all health care providers who administer vaccine injections. Recommendations for the management of fear in individuals with high levels of needle fear (i.e.,
individuals with persistent, intense apprehension
of or fear in response to a needle procedure,
who may endure needles with intense distress or
avoidance) are reported separately, as they
require knowledge and skills beyond those of
practitioners who usually give vaccinations
(C.M.M., unpublished data, 2015). Delayed
pain (hours to days after injection) was not considered in this guideline.

©2015 8872147 Canada Inc. or its licensors
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Team composition
The HELPinKids&Adults team included 25
individuals from across Canada with expertise
in pain, fear, medicine, nursing, pharmacy, psychology, vaccinology, infectious diseases, epidemiology, guideline development, knowledge
translation (KT), library sciences, public health,
family advisory/advocacy and health policy.
Eighteen members of the HELPinKids&Adults
team formed the guideline panel group.
The project was funded by the Canadian Institutes of Health Research, which had no input into
the guideline. Financial and intellectual conflicts of
interest were disclosed by all members. Individuals
with self-identified conflicts were allowed to participate in all discussions, but were excluded from
voting on guideline recommendations in areas of
conflict. One government agency representative
was an observer and did not participate in voting
on recommendations. Individuals from industries
manufacturing or distributing vaccines or pain
treatments were excluded from participating.
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reviewed.
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Guideline development
We used the AGREE II (Appraisal of Guidelines
for Research and Evaluation II) tool (www.agree
trust.org) as the overarching methodology for guideline development. GRADE (Grading of Recom-

Key points
•

Pain at the time of vaccine injection is a common concern and
contributes to vaccine hesitancy across the lifespan.

•

Evidence-based and feasible interventions are available to mitigate
pain and are part of good vaccination clinical practice.

•

This guideline includes recommendations for pain mitigation based on
five domains of pain management interventions (procedural, physical,
pharmacologic, psychological and process): the “5P” approach.
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mendations Assessment, Development and Evaluation) (www.gradeworkinggroup.org/publications/
jce_series.htm) and Cochrane (http://handbook.
cochrane.org) methods provided the general framework for the development of recommendations and
the synthesis of research evidence (Box 1).
All members of the HELPinKids&Adults
team participated in delineating the scope and
clinical questions, and reviewed and approved the
recommendations. The guideline panel group
reviewed the evidence base and approved the first
draft of the recommendations before consideration by the whole team. Two smaller working
groups oversaw the development of the evidence
base (Evidence Lead group) and knowledge
translation (KT group) aspects. The chair (A.T.)
oversaw all aspects of the project.
Practice recommendations were made for 49
clinical questions organized into five domains
of pain management interventions (the “5P”
approach): procedural, physical, pharmacologic,
psychological and process.
We identified relevant articles by searching
MEDLINE, Embase, PsycINFO, CINAHL and
ProQuest Dissertations & Theses Global from
their date of inception until Feb. 26, 2015. Systematic reviews were carried out for each domain;
the complete methodology used and results are
published separately.7–13 Self-reported pain was
typically identified as the critically important outcome in studies; however, related outcomes, such
as self-reported fear and, in the absence of selfreport (e.g., in infants and young children),
observer-rated distress, were often included.
Box 1: Summary of approach to guideline development
and recommendations
•

The GRADE (Grading of Recommendations Assessment, Development and
Evaluation) system provided the general framework for the formulation
of recommendations and the synthesis of the research evidence.

•

We rated candidate clinical questions; a two-thirds majority was set as
the cut-off for inclusion in the guideline.

•

We ranked the importance of each outcome on a scale of 1 to 9.
Outcomes with scores from 7 to 9 were classified as critically important,
those with scores from 4 to 6 were classified as important, and those
with scores from 1 to 3 were disregarded. Critically important outcomes
were prioritized for decision-making.

•

We performed systematic reviews for all included questions.

•

Quality of evidence across critical and important outcomes was assessed as
very low, low, moderate or high on the basis of five factors: methodologic
limitations, inconsistency, indirectness, imprecision and publication bias.

•

The overall quality was assessed based on the lowest confidence for
critical outcomes only.

•

We categorized recommendations as strong or weak on the basis of four
factors: balance between benefits and harms, strength of evidence for
critical outcomes, variability in patient values and preferences, and
resource implications.

•

Interventions with a large benefit and higher strength of evidence were
more likely to receive a strong recommendation.
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The perspective of the individual undergoing
vaccination was prioritized for decision-making.
Because pain is an iatrogenic harm of vaccination,
even small mitigation benefits were considered to
be clinically significant. Recommendations were
generally applied to broad developmental stages:
infants and young children (≤ 3 yr), children (3–12
yr), adolescents (12–17 yr) and adults (≥ 18 yr).
Where deemed appropriate, further subdivisions
were made or categories collapsed.
The guideline was reviewed using the AGREE
II framework by individuals and organizations,
including the World Health Organization. Changes
were made to address concerns raised and then the
guideline was finalized.

Recommendations
The recommendations are summarized in
Table 1 and in age-based algorithms (Appendices 1–4, available at www.cmaj.ca/lookup/suppl/
doi:10.1503/cmaj.150391/-/DC1.) Strong recommendations are reviewed below.
Procedural interventions (injection
techniques)
We recommend that no aspiration be used during
intramuscular vaccine injections in individuals of
all ages (strong recommendation; very low confidence in estimates of effect).
Aspiration, a long-standing practice with injection of medications, can increase pain because of
the combined effects of a longer needle dwelling
time in the tissues and sheering action (wiggling)
of the needle. In two studies including 313
infants, there was a benefit to not aspirating on
infant acute distress (standardized mean difference [SMD] –0.82, 95% confidence interval [CI]
–1.18 to –0.46).8 Aspiration is unnecessary for
vaccine injections because of the lack of major
blood vessels in the anatomic sites used for injection.14 In many countries, auto-disable syringes
are already used, which preclude aspiration. Slight
bleeding at the injection site is common with vaccine injections and does not signal incorrect injection technique. There are no documented harms of
not aspirating before vaccination. It is a cost-neutral
intervention for pain mitigation.
We recommend injecting the most painful vaccine
last (rather than first) during vaccine injections in
individuals of all ages (strong recommendation;
moderate confidence in estimates of effect).
Many individuals receive more than one vaccine injection at a single visit. The order of vaccine
injection matters to overall pain because some vaccines are inherently more painful than others, and
pain can escalate with each subsequent injection
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(i.e., increased pain intensity following repeated
painful stimuli, or hyperalgesia).15 In two studies
including 196 infants, lower overall infant acute
distress was observed when the most painful vaccine was given last (SMD –0.69, 95% CI –0.98 to
–0.40).8 There are no cost implications or identified harms from this intervention. Examples of
painful vaccines that should be given last include
M-M-R II and Prevnar.6,8
Physical interventions (body position
and activity)
We recommend breastfeeding be used during
vaccine injections in children two years and
younger (strong recommendation; very low confidence in estimates of effect).

Breastfeeding is one of the most important
factors in promoting optimal health and is recommended for infants up to two years or
beyond (www.who.int/nutrition/topics/infant
feeding_recommendation/en). Breastfeeding is
hypothesized to reduce distress via multiple
mechanisms, including physical comfort, sucking,
distraction and ingestion of sweet-tasting and other
substances that may have, individually and
together, distress-relieving effects. A meta-analysis
including 792 infants showed a large benefit of
breastfeeding during vaccination (SMD –1.78,
95% CI –2.35 to –1.22).9 Breastfeeding is a costneutral intervention and does not require additional
time beyond the need to latch the infant. Some
privacy and a chair are suggested. Alternatives to

Table 1 (part 1 of 3): Recommendations for reducing pain during vaccine injections

Treatment

Recommendation

Confidence

Infants and
young children
(≤ 3 yr)

Children
(3–12 yr)

Adolescents
(12–17 yr)

Adults
(≥ 18 yr)

Strong recommendations
Procedural interventions
No aspiration

We recommend no aspiration during
intramuscular vaccine injections

Very low

Yes

Yes

Yes

Yes

Order of injection

We recommend injecting the most painful
vaccine last during vaccine injections

Moderate

Yes

Yes

Yes

Yes

Breastfeeding*

We recommend breastfeeding during
vaccine injections

Very low

Yes
(≤ 2 yr)

—

—

—

Positioning:
skin-to-skin contact†

We recommend skin-to-skin contact during
vaccine injections

Moderate

Yes
(≤ 1 mo)

—

—

—

Positioning: holding†

We recommend holding during vaccine
injections

Very low

Yes

—

—

—

If holding is not used during vaccine
injections, we recommend a combined
holding intervention (including patting and/
or rocking) after vaccine injections

Low

Yes

—

—

—

We recommend sitting up during vaccine
injections

Low

—

Yes

Yes

Yes

Physical interventions

Positioning: sitting up

Pharmacologic interventions
Topical anesthetics

We recommend topical anesthetics before
vaccine injections

Very low

Yes

Yes

—§

—§

Sweet-tasting
solutions†‡

We recommend sucrose solutions before
vaccine injections

Moderate

Yes
(≤ 2 yr)

—

—

—

We recommend glucose solutions before
vaccine injections

Moderate

Yes
(≤ 2 yr)

—

—

—

Low

Yes

Yes

Yes

Yes

Process interventions
Education of clinicians

We recommend education of clinicians
administering vaccine injections about
vaccine injection pain management

Parent presence

We recommend presence of parents during
vaccine injections

Very low

Yes

Yes
(≤ 10 yr)

—

—

Education of parents

We recommend education of parents about
pain management for vaccine injection
before the day of vaccination

Low

Yes

Yes

Yes

—

We recommend education of parents about
pain management for vaccine injection on
the day of vaccination

Very low

Yes

Yes

Yes

—

We recommend education of individuals
about pain management for vaccine
injection on the day of vaccination

Very low

—

Yes

Yes

Yes

Education of
individuals
undergoing
vaccination

CMAJ, September 22, 2015, 187(13)
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breastfeeding include bottle-feeding with
expressed breast milk or formula throughout the
procedure, which simulates aspects of breastfeeding. Other alternatives are described below.
We recommend holding be used (rather than the
child lying supine) during vaccine injections in children three years and younger (strong recommendation; very low confidence in estimates of effect).
Positioning that is comfortable and promotes
proximity soothing from a caregiver should be

used.16 Neonates that are not breastfed can be
positioned skin-to-skin (also known as “kangaroo
care”), which involves placing a diaper-clad baby
prone on the mother’s bare chest before commencing vaccine injection and continuing during
and afterwards. In three studies including 736
neonates, skin-to-skin contact reduced acute distress during the procedure (SMD –0.65, 95% CI
–1.05 to –0.25).8 Holding infants during vaccination reduces acute distress (SMD –1.25, 95% CI
–2.05 to –0.46; n = 107).8 Holding interventions

Table 1 (part 2 of 3): Recommendations for reducing pain during vaccine injections

Confidence

Infants and
young children
(≤ 3 yr)

Children
(3–12 yr)

Adolescents
(12–17 yr)

Adults
(≥ 18 yr)

We suggest simultaneous injections (rather
than sequential injections) during vaccine
injections

Low

Yes (≤ 1 yr)§

—§

—

—

We suggest against simultaneous injections
during vaccine injections

Very low

Yes§
(1–3 yr)

Yes
(≤ 10 yr)

—

—

We suggest the vastus lateralis (rather than
the deltoid) as the site of injection during
vaccine injections

Low

Yes
(≤ 11 mo)

—

—

—

Breastfeeding*

If breastfeeding is not used during vaccine
injections, we suggest breastfeeding before
vaccine injections

Low

Yes
(≤ 2 yr)

—

—

—

Nonnutritive sucking†

We suggest nonnutritive sucking (using a
thumb/finger, pacifier) during vaccine
injections

Low

Yes
(≤ 2 yr)

—

—

—

Vibrating device
with cold

We suggest an external vibrating device
with cold during vaccine injections

Low

—

Yes

Yes

—

Muscle tension

We suggest muscle tension for vaccine
injections in individuals with a history of
fainting

Very low

—

Yes
(≥ 7 yr)

Yes

Yes

Manual tactile
stimulation

We suggest against manual tactile
stimulation during vaccine injections

Very low

Yes

Yes

Yes

Yes

Warming the vaccine

We suggest against warming the vaccine
before vaccine injections

Low

Yes

Yes

Yes

Yes

Moderate

—§

—§

Yes

Yes

Treatment

Recommendation

Weak recommendations
Procedural interventions
Simultaneous
injection

Vastus lateralis

Physical interventions

Pharmacologic interventions
Topical anesthetics

We suggest topical anesthetics before
vaccine injections

Topical anesthetics
and breastfeeding*

We suggest combining topical anesthetics
before vaccine injections and breastfeeding
during vaccine injections

Low

Yes
(≤ 2 yr)

—

—

—

Sweet-tasting
solutions and
nonnutritive
sucking†‡

We suggest sweet-tasting solutions (sucrose,
glucose) before vaccine injections and
nonnutritive sucking (thumb/finger,
pacifier) during vaccine injections

Very low

Yes
(≤ 2 yr)

—

—

—

Vapocoolants

We suggest against applying vapocoolants
before vaccine injections

Low

Yes

Yes

Yes

—§

We suggest that vapocoolant spray be used
before vaccine injections

Low

—§

—§

—§

Yes

Acetaminophen

We suggest against giving acetaminophen
before vaccine injections

Low

Yes

Yes

Yes

Yes

Ibuprofen

We suggest against giving ibuprofen before
vaccine injections

Very low

Yes

Yes

Yes

Yes

Sweet-tasting
solutions and
breastfeeding

We suggest against using sweet-tasting
solutions (sucrose, glucose) and
breastfeeding in combination before
vaccine injections

Low

Yes
(≤ 2 yr)

—

—

—

978
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applied after vaccine injections should combine
patting and/or rocking.8
We recommend sitting upright be used (rather
than the individual lying supine) during vaccine
injections in children three years and older and
adults (strong recommendation; low confidence
in estimates of effect).
Sitting upright promotes a sense of control in
individuals undergoing vaccination, which can
have a positive impact on their experience of pain.
Sitting upright has been shown to decrease fear
(SMD –0.39, 95% CI –0.77 to –0.01; n = 107) and
observed distress (SMD –10.3, 95% CI –20.18
to –0.42; n = 107) in children.8 Children can sit on
a parent’s lap; this can also assist with keeping still
the limbs to be vaccinated. Forcibly restraining

children should be avoided because this can
increase fear. Children, adolescents and adults can
sit upright on their own.
Pharmacologic interventions
(pain medicine)
We recommend topical anesthetics be applied
before vaccine injections in children 12 years
and younger (strong recommendation; very low
confidence in estimates of effect).
Topical anesthetics are local anestheticcontaining creams, gels and patches that block
transmission of pain signals from the skin.17 Topical anesthetics are a well-established therapy for
the mitigation of needle-related pain in individuals
of all ages. In a meta-analysis including 1424
children undergoing vaccination, there was a sub-

Table 1 (part 3 of 3): Recommendations for reducing pain during vaccine injections

Treatment

Recommendation

Confidence

Infants and
young children
(≤ 3 yr)

Children
(3–12 yr)

Adolescents
(12–17 yr)

Adults
(≥ 18 yr)

Weak recommendations cont’d
Psychological interventions
Verbal signal of
impending procedure

We suggest a verbal signal of the
impending procedure (v. a signal of
impending pain) before vaccine injections

Very low

Yes

Yes

Yes

Yes

Distraction

We suggest directed video distraction
during vaccine injections

Very low

Yes

—§

—

—

We suggest directed toy distraction during
vaccine injections

Very low

Yes

—

—

—

We suggest nondirected toy distraction
during vaccine injections

Very low

Yes

—

—

—

Low

—

Yes

—

—

We suggest video distraction during vaccine
injections

Very low

—§

Yes

—

—

We suggest music distraction during vaccine
injections

Low

—

Yes

—§

—§

We suggest against music distraction during
vaccine injections

Very low

—

—§

Yes

Yes

We suggest against visual distraction during
vaccine injections

Very low

—

—

—

Yes

We suggest breathing with a toy distraction
(e.g., blowing bubbles, pinwheel) during
vaccine injections

Very low

—

Yes

—

—

We suggest against breathing without a toy
distraction (blowing, deep breathing)
during vaccine injections

Very low

—

Yes

—

—

We suggest against breathing interventions
(cough) during vaccine injections

Low

—

Yes

Yes

—§

We suggest breathing interventions (cough,
breath-hold) during vaccine injections

Very low

—

—§

—§

Yes

Low

Yes

Yes

Yes

Yes

Very low

Yes

Yes

Yes

Yes

We suggest verbal distraction during
vaccine injections

Breathing distraction

Using suggestion

We suggest against using false suggestion
during vaccine injections

Using reassurance

We suggest against using repeated
reassurance during vaccine injections

*Alternatively, bottle feeding with expressed breast milk or formula can be used, or combined interventions that simulate breastfeeding (e.g., holding, sweet-tasting solution,
sucking), as appropriate.
†If not breastfeeding.
‡Alternatively, if oral rotavirus vaccine is being administered at the same time as injectable vaccines, rotavirus vaccine can be given first as it contains sucrose.
§See elsewhere in the table for a recommendation in this age group.

CMAJ, September 22, 2015, 187(13)
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stantial benefit of topical anesthetics on acute distress (SMD –0.91, 95% CI –1.36 to –0.47).9 There
is no evidence of an adverse effect of topical anesthetics on the vaccine immune response.9 The provision of topical anesthetics should be a standard
preventive measure for children, who cannot advocate for themselves and are at risk of long-term
harm from unmitigated pain due to the development of needle fears. The majority of children are
afraid of needles and report a preference for analgesics to be used.2,18 Because topical anesthetics
incur additional time and costs, their use requires
some planning. In many cases, they can be accommodated in usual clinic waiting times.19 Otherwise,
they can be applied before clinic arrival.
We recommend giving sucrose solution before
vaccine injections in children two years and
younger (strong recommendation; moderate
confidence in estimates of effect).
Children who are not breastfed during vaccine
injections can be given sweet-tasting solutions. In
the hospital setting, sweet-tasting solutions are an
established treatment for pain. Their mechanism of
action is not known, but may involve release of
endogenous opioids and distraction. In a meta-analysis including 2071 infants undergoing vaccination,
the benefit of sucrose solution on infant distress was
significant (SMD –0.76, 95% CI –1.19 to –0.34).9
The typical dose is 2 mL of a 24% to 50% strength
solution administered about one to two minutes
before injection; glucose can be used if sucrose is
not available. This intervention requires additional
resources for acquisition of commercially available
preparations or manufacturing by clinicians or parents. Alternatively, for infants scheduled to receive
oral rotavirus vaccine at the same time as injectable
vaccines, rotavirus can be given first because it
contains sucrose (as a flavouring agent), which
obviates the need for sweet-tasting solutions.20
Process interventions (education
and implementation)
We recommend education of clinicians administering vaccine injections about pain management (strong recommendation; low confidence in
estimates of effect).
Clinicians administering vaccinations are
required to be competent in vaccine administration techniques, and this includes pain mitigation. Clinician education increases the use of
pain interventions during vaccination (SMD
0.66, 95% CI 0.47 to 0.85; n = 459).13
We recommend that parents be present during vaccine injections in children 10 years and younger
(strong recommendation; very low confidence in
estimates of effect).
980
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Children show lower levels of distress when
parents stay before vaccine injections than when
parents leave (SMD –0.85, 95% CI 1.35 to
–0.35; n = 67) and prefer to have their parents
present.13 Family-centred health care promotes
caregiver presence whenever possible.21 Because
parents’ behaviour can influence a child’s level
of distress, education of parents is recommended
to facilitate child coping and to alleviate pain,
fear and distress (see below).
We recommend education of parents about pain
management before the day of vaccination
(strong recommendation; low confidence in estimates of effect).
Parents want to learn about strategies for pain
mitigation.2 Education of parents ahead of time
increases use of pain interventions during vaccination (relative risk [RR] 2.08, 95% CI 1.51 to
2.86; n = 300).13
We recommend education of parents about pain
management on the day of vaccination (strong
recommendation; very low confidence in estimates
of effect).
Educating parents on the day of vaccination
increases use of pain interventions during vaccination (RR 2.42, 95% CI 1.47 to 3.99; n = 239).13
Opportunities to learn ahead of time support
planning and practice.
We recommend education of children three years
and older and adults about pain management on
the day of vaccination (strong recommendation;
very low confidence in estimates of effect).
Individuals undergoing vaccination should be
given information about what will happen (procedural information), how it will feel (sensory
information) and how to cope (training in strategies to mitigate pain and fear).22–24 Information
should mostly be given in advance. At the time
of the procedure, the focus should be on neutral
information about the procedure and coping
strategies rather than threatening sensory information that can increase fear. There is evidence
that education reduces preprocedural fear in children undergoing vaccination (SMD –0.67, 95%
CI –1.28 to –0.07; n = 51).13

Implementation
No single intervention included in this guideline
is expected to prevent all pain (i.e., achieve a
level of pain of “0”). Individual interventions
can be combined, as appropriate, to improve
pain relief. For young and school-aged children,
because of the high levels of distress with vaccine injections and higher potential for long-term
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harm (i.e., development of needle fear and health
care avoidance), a more comprehensive and consistent approach is recommended. With maturity,
a more self-directed and individualized approach
can be used.
Pain mitigation is considered part of good
vaccination clinical practice by the World Health
Organization, which has accepted the most practical interventions from this guideline for global
implementation.25 All involved in vaccination
programs need to identify and support clinician
interest, willingness and ability to adopt these
guideline recommendations to achieve best practices. Additional resources (e.g., supplies, personnel) may be required to educate and support
clinicians, parents and individuals to implement
these recommendations.
Methods already used for education about
vaccination (e.g., verbal instruction, pamphlets,
videos) are effective for education about pain
mitigation. Sample resources are currently available from Immunize Canada (www.immunize.
ca) and HELPinKids&Adults (http://phm.
utoronto.ca/helpinkids). Training can occur
across various different clinical (e.g., hospital,
outpatient clinic) and educational (e.g., prenatal
class, school) settings.
Importantly, many pain mitigation interventions can be offered for little or no cost. Even for
those with costs, the costs may be offset by
avoiding the costs of subsequent harm from
unmitigated pain and fear, including the negative
impact on health outcomes due to vaccine hesitancy and noncompliance with other health care
interventions, and the costs for treatment of needle fears that have developed due to poorly managed pain. Performance metrics can include clinical indicators (e.g., pain intensity, fear intensity),
process indicators (e.g., use of pain interventions,
compliance with vaccination) and conceptual
indicators (e.g., knowledge, satisfaction). Appendix 5 (available at www.cmaj.ca/lookup/suppl/
doi:10.1503/cmaj.150391/-/DC1) and a global
vaccine safety research network (https://brighton
collaboration.org)26 offer some sample tools for
assessing pain and related outcomes, and documenting pain interventions used.
We plan to update the guideline in the next
5–10 years (2019–2024), depending on the availability of new research evidence and project
funding.

Other guidelines
The differences between the original 2010 guideline6 and the current guideline are summarized in
Appendix 6, available at www.cmaj.ca/lookup/
suppl/doi:10.1503/cmaj.150391/-/DC1.

Gaps in knowledge
The guideline recommendations are limited to the
available evidence, and certain recommendations
have more research support than others. There
was a noticeable gap in research evidence for
adolescent and adult populations, and mass vaccination settings, even though concerns about pain
and fear are well documented and contribute to
vaccine hesitancy. School-based vaccinations
should be specifically targeted to facilitate more
positive experiences with health care for children.
Data are needed on the painfulness of different vaccines (including their route of administration), aspects of vaccine injection technique (e.g.,
speed of injection and injection in a single limb
for multiple vaccine injections), and vaccine formulations and delivery systems that minimize
pain. Given the potential role of memory for pain
and fear in subsequent experiences of pain,27
research is needed to examine the efficacy of
interventions for memory reframing. Studies on
the impact of pain interventions on future pain
and vaccine compliance are also warranted to
show the long-term impact of pain interventions.

Conclusion
Pain during vaccination is an important concern
across the lifespan. This guideline provides recommendations for interventions that can mitigate vaccination pain. Many interventions are
feasible across vaccination settings. The fulllength guideline is available in Appendix 7,
available at www.cmaj.ca/lookup/suppl/doi:
10.1503/cmaj.150391/-/DC1.
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